SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-005471
Filing Date
2023-03-06
Accepted
2023-03-06 08:30:16
Documents
15
Period of Report
2023-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20230303_8k.htm   iXBRL 8-K 39312
2 EXHIBIT 99.1 ex_483603.htm EX-99.1 7859
7 dt01.jpg GRAPHIC 6228
  Complete submission text file 0001437749-23-005471.txt   194103

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20230301.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20230301_def.xml EX-101.DEF 11517
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20230301_lab.xml EX-101.LAB 15384
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20230301_pre.xml EX-101.PRE 11673
9 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20230303_8k_htm.xml XML 2561
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 23707660
SIC: 2834 Pharmaceutical Preparations